-
In 2020, it will sell for 1.776 billion U.S. dollars, and AstraZeneca Olapali will be approved for new indications in China
Time of Update: 2021-07-28
In December 2019, the drug was approved by the NMPA for first-line platinum-based chemotherapy in newly-treated adult patients with germline or somatic BRCA mutations (gBRCAm or sBRCAm) advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer Maintenance treatment after complete remission or partial remission is achieved .
-
The highest drop is 93.61%!
Time of Update: 2021-07-28
The non-selected original research drugs, reference preparations, and generic drugs that have passed the consistency evaluation shall be capped by the lowest price of the bid-winning/listed online price currently being implemented on the national provincial platform and the low price of the “Shanghai Red Line Price” of the same variety as the upper limit.
-
Liao Fulong: Artemisinin research reflects the spirit of Chinese researchers
Time of Update: 2021-07-28
"The discovery of artemisinin reflects not only an original Chinese medicine in the international medical and health field, but also reflects the spiritual outlook of a generation of Chinese scientific researchers, that is, their responsibility and responsibility for national tasks .
-
Popular Science: What is the Delta Strain of New Coronary Mutant Virus
Time of Update: 2021-07-28
The World Health Organization said on the 21st that the delta strain of the new crown virus has now spread to 92 countries .
However, experts in many countries believe that the current vaccination is still effective, at least it can prevent severe illness and reduce deaths .
-
Zhang Wenhong: Vaccine is expected to end the new crown epidemic
Time of Update: 2021-07-28
Zhang Wenhong said that if nothing happens, by the end of June this year, China is expected to complete the vaccination target for 40% of the population .
Zhang Wenhong said that at present, scientists around the world generally believe that the possibility of eliminating infectious diseases is very small .
-
Chinese scientists have discovered a new type of small molecule compound for the treatment of liver cancer
Time of Update: 2021-07-28
My scientist discovered a new type of small molecule compound for the treatment of liver cancer My scientist discovered a new type of small molecule compound for the treatment of li
-
Top ten pharmaceutical companies accelerate R&D strategy adjustment
Time of Update: 2021-07-28
Combination of investment transactions and asset divestiture activities in the first quarter In recent years, with the rapid development of innovative biotechnology companies, large global pharmaceutical companies have launched cooperation models such as acquisitions and investments to quickly supplement their new drug R&D pipelines .
-
How to do drug immunogenicity research in the new registration era?
Time of Update: 2021-07-28
Immunogenic drugs may induce harmful immune responses in the body, and can form anti-drug antibodies and neutralizing antibodies.
-
Expert: The new crown vaccine has a good protection effect on minors
Time of Update: 2021-07-28
Zheng Huizhen, chief expert on disease control of the Guangdong Provincial Preventive Medicine Association, said in an interview during the meeting that the results of the study of healthy children and adolescents vaccinated with the new crown vaccine between the ages of 3 and 17 show that the safety and immunogenicity data are good, and the epidemic situation is serious.
-
The embryonic form of the Super Collective Alliance has begun!
Time of Update: 2021-07-28
On March 18, the Zhejiang Pharmaceutical Equipment Procurement Platform issued the "Notice on Carrying out the National Medical Insurance Medical Consumables Code Matching Work".
The document shows that Zhejiang will carry out basic information matching work for all medical consumables within the scope of centralized procurement in the province .
-
The new crown variant strain delta has spread to 92 countries and the vaccine is still effective
Time of Update: 2021-07-28
Although a recent study published in The Lancet showed that against the Delta strain, the titers of neutralizing antibodies produced by the human body after being vaccinated with the new crown vaccine have been reduced, but Van Kelkhover emphasized that the vaccine is effective for prevention.
-
Notice on the implementation of guardian management of standard varieties of pharmaceutical packaging materials in the "Chinese Pharmacopoeia"
Time of Update: 2021-07-28
cn Attachment: Contact Information of "Variety Guardian" in the "Chinese Pharmacopoeia" drug packaging standard National Pharmacopoeia Committee April 9, 2021 annex Contact information of "Variety Guardian" in the "Chinese Pharmacopoeia" drug packaging material standard standard name Responsible unit contact number Contact Email 4001 121℃ Determination of water resistance of glass particles China Institute of Food and Drug test 010-67095110 rayradix@126.
-
New research is expected to predict the risk of Alzheimer's disease in advance
Time of Update: 2021-07-27
Professor Han Ying, chairman of the Chinese Alzheimer’s Disease Preclinical Alliance and chief physician of the Department of Neurology at Xuanwu Hospital, pointed out that before MCI, there is a subjective cognitive decline (SCD)-and this is the breakthrough point for intervention , Which is the key to the "secondary prevention" of Alzheimer's disease .
-
Pfizer's new crown vaccine caused by delta strain drops to 39%
Time of Update: 2021-07-27
Previous data from the Israeli Ministry of Health showed that from May 2 to June 5, the effective rate of Pfizer's vaccine in preventing new crown infections in Israel was 94.
-
Anhui starts the collection of cephalexin at the lowest price
Time of Update: 2021-07-27
On July 21, the Anhui Pharmaceutical Joint Procurement Office issued an announcement on the centralized procurement of cephalexin oral normal-release dosage forms .
The announcement clarified that the maximum effective declaration price for this renewal is 0.
Evaluation rules: The lowest price method after evaluation .
-
The new crown virus has spread in Europe in October 2019?
Time of Update: 2021-07-27
According to reports, scientists from the Milan Cancer Research Center-the National Cancer Institute (Istituto Nazionale Tumori) wrote in a new paper published on the 19th local time that the two laboratories collected a small amount of blood samples before the outbreak of the new crown epidemic.
-
China's generic drug development has changed dramatically in the past 6 years
Time of Update: 2021-07-27
Source: PharmaGo The huge market sales have become a driving force for companies to accelerate the completion of the consistency evaluation of generic drugs .
Source: PharmaGo Correspondingly, the number of products approved to pass the consistency evaluation of generic drugs is also increasing .
-
Health Commission: 48 new confirmed cases on the 22nd, 12 in China
Time of Update: 2021-07-27
As of 24:00 on July 22, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 663 confirmed cases (including 17 severe cases), 87,163 cured and discharged cases, and 4,636 deaths.
-
Zhong Nanshan: Dare to be a doctor
Time of Update: 2021-07-27
" Facing the flag, Chinese Academy of Engineering academician , director of the National Respiratory Disease Clinical Research Center, First Affiliated Hospital of Guangzhou Medical University, Zhong Nanshan solemn oath collar, two new developments in preparation of party members are Wuhan Take the form of remote video to solemnly swear .
-
Incomplete inventory of sky-high drugs
Time of Update: 2021-07-27
The same benefits of drugs mean that the unit price is higher, and the pharmaceutical companies need corresponding regular returns to cover the continuous research and development costs .
Different from the high-priced drugs listed above, the currently approved cell therapy product indications cannot be regarded as rare diseases.
